The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $699,915 in first-year total cost, median $699,915.
Most frequent study sections
- Special Emphasis Panel[ZNS1 SRB-B (37)]1
Most frequent institutions
- COGNITION THERAPEUTICS, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | Lead Optimization of receptor antagonist CT0093 for disease-modifying Alzheimer's1U01AG047059-01 | CATALANO, SUSAN M | COGNITION THERAPEUTICS, INC., PA | $699,915 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.